Welcome to our dedicated page for Crown Holdings SEC filings (Ticker: CCK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crown Holdings, Inc. filings document the regulatory record of a Pennsylvania packaging company with common stock listed on the New York Stock Exchange under CCK and long-dated debentures listed under CCK96. Form 8-K reports cover earnings releases, material agreements, executive appointments, director elections, and other corporate events tied to the company’s packaging operations and capital structure.
The company’s proxy materials disclose annual meeting matters, director elections, board governance, and compensation topics. Debt-related filings include credit agreement disclosures involving Crown subsidiaries and securities-listing actions, including Form 25 records for removed debenture classes.
Crown Holdings, Inc. (CCK) has filed a Form 144 notice covering the proposed sale of 500 common shares (aggregate market value ≈ $53.5 thousand) through Wells Fargo Clearing Services on or about 10 July 2025 on the NYSE. The shares represent a negligible 0.0004 % of the company’s 116,392,214 shares outstanding. The seller, James Miller, originally received the shares in October 2015 as compensation.
The filing also discloses that the same individual sold 5,500 shares over the prior three months for gross proceeds of roughly $566.4 thousand across three transactions dated 11 June, 2 July, and 9 July 2025.
No adverse information regarding Crown Holdings' operations is reported, and the filer affirms awareness of Rule 10b5-1 obligations. Given the very small size relative to total float, the transaction is routine and is unlikely to have any material impact on valuation or market liquidity.
On July 1, 2025, Crown Holdings (ticker: CCK) President, Asia-Pacific Division John M. Rost reported the receipt of 2,910 restricted shares of the company’s common stock under the 2022 Stock-Based Compensation Plan, as disclosed in a Form 4 filing.
The award is structured as follows:
- 1,107 time-vested shares vest in three equal tranches of 369 shares on Aug 3, 2026, Jan 4, 2027 and Jan 3, 2028.
- 685 performance-based shares may vest on Jan 3, 2028 depending on relative Total Shareholder Return; payout range: 0-200 % of target.
- 1,118 performance-based shares may vest on Jan 3, 2028 contingent on Return on Invested Capital; payout range: 0-100 % of target.
All shares were acquired at $0 cost; no dispositions occurred. Following the grant, Rost’s reported holdings total 9,210 directly owned shares plus 264 shares held indirectly via the company 401(k) plan.
This filing represents a routine incentive-based equity grant designed to align executive interests with shareholders rather than an open-market purchase or sale. The size of the award is modest relative to Crown Holdings’ public float and therefore is unlikely to materially impact share supply-demand dynamics.
Crown Holdings, Inc. (CCK) – Form 4 insider filing dated 07/03/2025.
Executive Vice President & Chief Operating Officer Djalma Novaes Jr. reported the acquisition of 2,082 shares of restricted common stock on 07/01/2025 under the company’s 2022 Stock-Based Compensation Plan. The grant was recorded at a price of $0 because it represents equity compensation rather than an open-market purchase.
Breakdown of the award:
- 792 time-vested shares vest in three equal installments: 264 shares on 08/03/2026, 264 on 01/04/2027 and 264 on 01/03/2028.
- 490 performance-based shares vest on 01/03/2028 subject to Total Shareholder Return (TSR) vs. a peer group, with payout ranging from 0–200 % of target.
- 800 performance-based shares vest on 01/03/2028 based on Return on Invested Capital (ROIC), with payout ranging from 0–800 shares.
Following this grant, Novaes’ direct beneficial ownership rises to 116,595 shares.
No derivative securities were reported, and there were no dispositions of shares. The filing was signed by attorney-in-fact Rosemary Haselroth on 07/03/2025.